We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Norian Settles Charges Stemming From Unapproved Clinical Trials
Norian Settles Charges Stemming From Unapproved Clinical Trials
October 13, 2010
Synthes and its subsidiary Norian will pay more than $23 million to resolve felony and misdeameanor charges relating to unapproved clinical trials of bone-cement products that resulted in three deaths.